178 related articles for article (PubMed ID: 24175745)
1. Development of lysophosphatidic acid pathway modulators as therapies for fibrosis.
Budd DC; Qian Y
Future Med Chem; 2013 Oct; 5(16):1935-52. PubMed ID: 24175745
[TBL] [Abstract][Full Text] [Related]
2. Atx regulates skeletal muscle regeneration via LPAR1 and promotes hypertrophy.
Ray R; Sinha S; Aidinis V; Rai V
Cell Rep; 2021 Mar; 34(9):108809. PubMed ID: 33657371
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent inhibitors of the lysophospholipase autotaxin.
Shah P; Cheasty A; Foxton C; Raynham T; Farooq M; Gutierrez IF; Lejeune A; Pritchard M; Turnbull A; Pang L; Owen P; Boyd S; Stowell A; Jordan A; Hamilton NM; Hitchin JR; Stockley M; MacDonald E; Quesada MJ; Trivier E; Skeete J; Ovaa H; Moolenaar WH; Ryder H
Bioorg Med Chem Lett; 2016 Nov; 26(22):5403-5410. PubMed ID: 27780639
[TBL] [Abstract][Full Text] [Related]
4. Autotaxin facilitates selective LPA receptor signaling.
Salgado-Polo F; Borza R; Matsoukas MT; Marsais F; Jagerschmidt C; Waeckel L; Moolenaar WH; Ford P; Heckmann B; Perrakis A
Cell Chem Biol; 2023 Jan; 30(1):69-84.e14. PubMed ID: 36640760
[TBL] [Abstract][Full Text] [Related]
5. Crystalline silica particles induce DNA damage in respiratory epithelium by ATX secretion and Rac1 activation.
Wu R; Högberg J; Adner M; Stenius U; Zheng H
Biochem Biophys Res Commun; 2021 Apr; 548():91-97. PubMed ID: 33636640
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholines modulate immunoregulatory checkpoints in peripheral monocytes and are associated with mortality in people with acute liver failure.
Trovato FM; Zia R; Artru F; Mujib S; Jerome E; Cavazza A; Coen M; Wilson I; Holmes E; Morgan P; Singanayagam A; Bernsmeier C; Napoli S; Bernal W; Wendon J; Miquel R; Menon K; Patel VC; Smith J; Atkinson SR; Triantafyllou E; McPhail MJW
J Hepatol; 2023 Mar; 78(3):558-573. PubMed ID: 36370949
[TBL] [Abstract][Full Text] [Related]
7. Polyunsaturated lysophosphatidic acid as a potential asthma biomarker.
Ackerman SJ; Park GY; Christman JW; Nyenhuis S; Berdyshev E; Natarajan V
Biomark Med; 2016; 10(2):123-35. PubMed ID: 26808693
[TBL] [Abstract][Full Text] [Related]
8. Endothelial Specific Deletion of Autotaxin Improves Stroke Outcomes.
Bhattarai S; Subedi U; Manikandan S; Sharma S; Sharma P; Miller C; Bhuiyan MS; Kidambi S; Aidinis V; Sun H; Miriyala S; Panchatcharam M
Cells; 2023 Feb; 12(3):. PubMed ID: 36766854
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibition of EZH2 and the autotaxin-LPA-LPA2 axis exerts synergistic antitumor effects on colon cancer cells.
Long Y; Wang Y; Qu M; Zhang D; Zhang X; Zhang J
Cancer Lett; 2023 Jul; 566():216226. PubMed ID: 37230222
[TBL] [Abstract][Full Text] [Related]
10. Commonalities Between ARDS, Pulmonary Fibrosis and COVID-19: The Potential of Autotaxin as a Therapeutic Target.
Ntatsoulis K; Karampitsakos T; Tsitoura E; Stylianaki EA; Matralis AN; Tzouvelekis A; Antoniou K; Aidinis V
Front Immunol; 2021; 12():687397. PubMed ID: 34671341
[TBL] [Abstract][Full Text] [Related]
11. Molecular modelling guided design, synthesis and QSAR analysis of new small molecule non-lipid autotaxin inhibitors.
Banerjee S; Norman DD; Deng S; Fakayode SO; Lee SC; Parrill AL; Li W; Miller DD; Tigyi GJ
Bioorg Chem; 2020 Oct; 103():104188. PubMed ID: 32890995
[TBL] [Abstract][Full Text] [Related]
12. Autotaxin and Lysophosphatidic Acid Signalling: the Pleiotropic Regulatory Network in Cancer.
Vít O; Petrák J
Folia Biol (Praha); 2023; 69(5-6):149-162. PubMed ID: 38583176
[TBL] [Abstract][Full Text] [Related]
13. Linking the Autotaxin-LPA Axis to Medicinal Cannabis and the Endocannabinoid System.
Eymery MC; Boumendjel A; McCarthy AA; Hausmann J
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542186
[TBL] [Abstract][Full Text] [Related]
14. Disruption of LPA-LPAR1 pathway results in lung tumor growth inhibition by downregulating B7-H3 expression in fibroblasts.
Meng F; Yin Z; Lu F; Wang W; Zhang H
Thorac Cancer; 2024 Feb; 15(4):316-326. PubMed ID: 38124403
[TBL] [Abstract][Full Text] [Related]
15. Autotaxin-lysophosphatidic acid receptor 5 axis evokes endothelial dysfunction via reactive oxygen species signaling.
Janovicz A; Majer A; Kosztelnik M; Geiszt M; Chun J; Ishii S; Tigyi GJ; Benyó Z; Ruisanchez É
Exp Biol Med (Maywood); 2023 Oct; 248(20):1887-1894. PubMed ID: 37837357
[TBL] [Abstract][Full Text] [Related]
16. LPA signaling acts as a cell-extrinsic mechanism to initiate cilia disassembly and promote neurogenesis.
Hu HB; Song ZQ; Song GP; Li S; Tu HQ; Wu M; Zhang YC; Yuan JF; Li TT; Li PY; Xu YL; Shen XL; Han QY; Li AL; Zhou T; Chun J; Zhang XM; Li HY
Nat Commun; 2021 Jan; 12(1):662. PubMed ID: 33510165
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the enzyme autotaxin reduces cortical excitability and ameliorates the outcome in stroke.
Bitar L; Uphaus T; Thalman C; Muthuraman M; Gyr L; Ji H; Domingues M; Endle H; Groppa S; Steffen F; Koirala N; Fan W; Ibanez L; Heitsch L; Cruchaga C; Lee JM; Kloss F; Bittner S; Nitsch R; Zipp F; Vogt J
Sci Transl Med; 2022 Apr; 14(641):eabk0135. PubMed ID: 35442704
[TBL] [Abstract][Full Text] [Related]
18. Autotaxin inhibitor IOA-289 reduces gastrointestinal cancer progression in preclinical models.
Centonze M; Di Conza G; Lahn M; Fabregat I; Dituri F; Gigante I; Serino G; Scialpi R; Carrieri L; Negro R; Pizzuto E; Giannelli G
J Exp Clin Cancer Res; 2023 Aug; 42(1):197. PubMed ID: 37550785
[TBL] [Abstract][Full Text] [Related]
19. Experimental autotaxin inhibitors for the treatment of idiopathic pulmonary fibrosis.
Simonetti J; Ficili M; Sgalla G; Richeldi L
Expert Opin Investig Drugs; 2024 Feb; 33(2):133-143. PubMed ID: 38299617
[TBL] [Abstract][Full Text] [Related]
20. Cyclic phosphatidic acid - a unique bioactive phospholipid.
Fujiwara Y
Biochim Biophys Acta; 2008 Sep; 1781(9):519-24. PubMed ID: 18554524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
